Skip to content

Psychedelic-assisted therapy: all studies

Page 15 of 294: studies 141 to 150 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

Supporting desistance from crime: The promise of psychedelic-assisted therapy in correctional and reentry contexts.

International Journal of Drug Policy December 1, 2025 Tereza Dleštíková

This paper proposes a psychedelic theory of desistance, arguing that psychedelic-assisted therapy (PAT) may support the desistance from crime - the cessation of criminal behavior - by promoting identity transformation and personal meaning-making among criminal justice-involved individuals. Drawing from psychedelic science and desistance focused criminological theories, it suggests that, when...

The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy.

Current Topics in Behavioral Neurosciences November 22, 2025 Helena Aicher, Anke Röskamp, Marianne Moser et al. 4 citations

Touch has long been an essential element in human communication and healing. In the field of psychedelic-assisted therapy (PAT), the role of touch (and by extension, non-touch) presents complex ethical and practical challenges, particularly due to the heightened vulnerability of individuals in altered states of consciousness. Recent public discourse, including reports of boundary violations and...

DOI: 10.1007/7854_2025_608 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Body-oriented psychotherapy Harm reduction Transgressions +12

Ketamine-Assisted Psychotherapy for Treatment- Resistant Depression with Comorbid Post-Traumatic Stress Disorder in Veterans

Insight the psychological dimensions of society November 19, 2025 O. Orlov Aleksey, V. Zaika, O. Fitkalo

The aim of the study was to evaluate the practice of using ketamine-assisted psychotherapy (KAT) in accordance with international clinical guidelines at the State Institution "Center for Mental Health and Veterans' Rehabilitation 'Lisova Polyana' of the Ministry of Health of Ukraine" (Ukraine).Adapting the international clinical guidelines on ketamine therapy for treatmentresistant depression...

MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials

Journal of Psychoactive Drugs November 5, 2025 B Brett, Christine Bynum 4 citations

Posttraumatic stress disorder (PTSD) is a serious and chronic mental health condition with limited effective treatment options. 3,4-methylenedioxymethamphethamine (MDMA)-assisted psychotherapy (MDMA-AT) has shown promise in phase 2 and phase 3 clinical trials, with many research participants reporting significant reductions in PTSD symptoms. However, the Federal Drug Administration (FDA)...

DOI: 10.1080/02791072.2025.2577308 (opens in new tab) MDMA Placebo Randomized controlled trial Posttraumatic stress +7

Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy

Psychoactives November 2, 2025 Faith Ekoh, Shanice Rerrie, James Angud et al. 2 citations

Today’s research highlights the therapeutic potential of the hallucinogen psilocybin in the treatment of pathologies associated with mood, cognitive, and affective dysregulation. These domains of function are regulated by the serotonergic system, which can be influenced by sex hormones, like estrogen and testosterone, and psychedelic compounds including psilocybin. Current evidence supports a...

Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe's general change mechanisms.

Psychological Review November 1, 2025 Max Wolff, Hans Rutrecht, Lea J. Mertens et al.

Psychedelic therapy is commonly understood as a form of psychotherapy. However, despite promising results from clinical trials, scientific progress has been hindered by a lack of theoretical integration between the fields of psychedelic and psychotherapy research. This article seeks to bridge this divide by outlining a transtheoretical understanding of psychedelic-occasioned psychological...

Neutral attitude toward the utilization of psychedelic therapy for depression in the United Kingdom population.

International Journal of Drug Policy November 1, 2025 Liam O Jarvis, Alexander H Jack, Niall Galbraith et al. 1 citation

The global prevalence of depression is high, and there are concerns about the therapeutic effectiveness of current treatments. Research over the past two decades has led to a new class of alternative treatments termed 'psychedelic-assisted therapy (PAT).' This study aimed to investigate the attitudes toward the application and use of psychedelic-assisted therapies in the United Kingdom...

Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review

BJPsych Open November 1, 2025 Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin et al. 2 citations

Background Psilocybin-assisted psychotherapy (PAP) has gained attention as a promising intervention for conditions including depression, anxiety and post-traumatic stress disorder, but understanding of its side-effects is limited. This review evaluates the quality of side-effects reporting in PAP trials, to guide treatment, policy and research. Aims To assess side-effects reporting quality in...

DOI: 10.1192/bjo.2025.10847 (opens in new tab) Clinical trial Medline Systematic review Alternative medicine +2

Provider perspectives on challenges in treatment during psychedelic therapy.

Psychopharmacology October 27, 2025 David A Bender, Sandeep M. Nayak, Joshua S. Siegel et al.

Psychedelic treatments are considered to involve unique treatment challenges relative to other psychiatric interventions, though these are typically not explored in detail within clinical trial reports. To determine the types of challenges that providers encounter while administering psychedelic drugs in research settings and to assess provider opinions on safeguards that may be pursued to...